Nucleosides VIII: Synthesis of 2',3'-dideoxy- and 2',3'- didehydro- 2',3'-dideoxyisoguanosine as potential antiretroviral agents

Nucleosides and Nucleotides

Volumn 15, Issue 7-8, 1996, Pages 1253-1261

  Chen, Chien Shu ^a   Chern, Ji Wang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEHYDRO 2',3' DIDEOXYISOGUANOSINE; 2',3' DIDEOXYISOGUANOSINE; ANTIVIRUS AGENT; CROTONOSIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG ACTIVITY; DRUG METABOLISM; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

EID: 0029943676     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608002427     Document Type: Article

References (20)

1. Previous paper in this series: Chien, T.-C.; Chen, C.-S.; Yeh, J.-Y.; Wang, K.C.; Chern, J.-W. Tetrahedron Lett. 1995, 36, 7881.
2. a) Mitsuya, H.; Broder, S. Proc. Natl. Acad. Sci. USA 1986, 83, 1911.
3. b) Lin, T.-S.; Schinazi, R. F.; Prusoff, W. H. Biochem. Pharmacol. 1987, 36 2713.
4. c) Mitsuya, H.;Yarchoan, R.; Broder, S. Science 1990, 249, 1533 and references cited therein.
5. Cherbuliez, E.; Bernahard, K. Helv. Chim. Acta. 1932, 15, 464.
6. a) Ewing, P. L.; Schlenk, F.; Emerson, G. A. J. Pharmacol. Exp. Ther. 1949, 97, 379.
7. b) Clarke, D. A.; Davoll, J.; Phillips, F. S.; Brown, G. B. J. Pharmacol. Exp. Ther. 1952, 706, 291.
8. c) Bruns, R. F.; Lu, G. H.; Pugsley, T. A. Mol. Pharmacol. 1986, 29, 331.
9. Balzarini, J.; Pauwels, R.; Baba, M.; Robins, M. J.; Zou, R.; Herdewijn, P.; De Clercq, E. Biochem. Biophys. Res. Commun. 1987, 145, 269.
10. a) Chu, C. K.; Bhadti, V. S.; Doboszewski, B.; Gu, Z. P.; Kosugi, Y.; Pullaiah, K. C.; Van Roey, P. J. Org. Chem. 1989, 54, 2217.
11. b) Mansuri, M. M.; Starrett, J. E. Jr.; Wos,J. A.; Tortolani, D. R.; Brodfuehrer, P. R.; Howell, H. G.; Martin, J. C. J. Org. Chem. 1989, 54, 4780.
12. a) Corey, E. J.; Winter, R. A. E. J. Am. Chem. Soc. 1963, 85, 2677.
13. b) Corey, E. J.; Carey, F.; Winter, R. A. E. J. Am. Chem. Soc. 1965, 87, 934.
14. a) Barton, D. H. R.; Subramanian, R. J. Chem. Soc., Perkin Trans. 1 1977, 1718.
15. b) Doboszewski, B.; Chu, C. K.; Van Halbeek, H. J. Org. Chem. 1988, 53, 2777.
16. a) Chern, J.-W.; Lee, H.-Y.; Huang, M.; Shish, F.-J. Tetrahedron Lett. 1987, 28, 2151.
17. b) Chern, J.-W.; Lin, G.-S.; Chen, C.-S.; Townsend, L. B. J. Org. Chem. 1991, 56, 4213.
18. a) Lehrfeld, J. J. Org. Chem. 1967, 32, 2544.
19. b) Rosowsky, A.; Solan, V. C.; Sodroski, J. G.; Ruprecht, R. M. J. Med. Chem. 1989, 32, 1135.
20. Antiviral assay data were obtained by the laboratories of John C, Drach (department of Biologic and Material Sciences, School of Dentistry, The University of Michigan, Ann Arbor, MI 48109, USA). The methods for these assays have been described previously: Devivar, R. V.; Kawashima, E.; Revankar.G. R.; Breitenbach, J. M.; Kreske, E. D.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1994, 37, 2942.